The material from Koi is a research-grade lyophilized peptide vial with analytical documentation (HPLC, LC-MS, endotoxin) built around in vitro laboratory use, not patient-directed compounding, dispensing, or any clinical workflow
Common Anecdotal Reports Appetite suppression: Most users report strong hunger reduction even at lower doses (2-4mg) Energy levels: Mixed
Individual results vary based on age, health status, lifestyle factors, and treatment adherence
PLGA nanoparticles offer sustained release characteristics that could compensate for the lower bioavailability of nasal delivery by providing a continuous supply of peptide to the absorption site
Always discuss genetic findings, test results, symptoms, and treatment decisions with your healthcare provider or an allergist to determine appropriate care for your situation